Cisplatin is classified as a platinum compound and an alkylating cytotoxic agent. Much of our current understanding of the unique properties of platinum drugs has come from studies of cisplatin, especially its antitumor activity. The antitumor activity of platinum (II) complexes requires several unique chemical properties including the presence of chloride, bromide, oxalate, or malonate as leaving group and the neutral complex with inert carrier ligands such as NH3 groups. Minor variations in the structure of these ligands may have a profound effect on the antitumor activity and toxicity of platinum compounds. The cis conformation is required for a complex to be a biologically effective agent and has significant cytotoxic properties, while the transisomer does not.
Since the discovery of the antitumor potential of cisplatin by Rosenberg and coworkers,...
KeywordsTesticular Cancer Xeroderma Pigmentosum Nonsmall Cell Lung Cancer Cell ERCC1 Expression Human Nonsmall Cell Lung Cancer
- McEvoy GK (ed) (2004) AHFS 2004 drug information. American Society of Health-System Pharmacists, Bethesda, pp 929–945Google Scholar